Skip to main content

Table 1 Characteristics of the study population of patients tested for COVID-19

From: Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective

Characteristics Patients with hypertension
(N = 75,527)
All patients
(N = 234,427)
Median age (interquartile rage)- yr. 68 (23) 45 (35)
Female sex – no. (%) 35,761 (47.3) 122,480 (52.2)
Confirmed COVID-19- no. (%) 1911 (2.5) 7590 (3.2)
Diabetes mellitus- no. (%) 44,441 (58.8) 62,655 (26.7)
Cardiovascular disease- no. (%) 4705 (6.2) 5038 (2.1)
Cerebrovascular disease- no. (%) 14,503 (19.2) 17,519 (7.5)
Ischemic heart disease- no. (%) 12,122 (16) 14,191 (6.1)
COPD- no. (%) 4871 (6.4) 6612 (2.8)
Malignancy- no. (%) 14,368 (19) 24,628 (10.5)
Renal replacement therapy- no. (%) 4338 (5.7) 4525 (1.9)
ACEIs or ARBs- no. (%) 13,116 (17.4) 13,240 (5.6)
\